» Articles » PMID: 6153937

Lung Damage from Cytotoxic Drugs

Overview
Specialty Oncology
Date 1980 Jan 1
PMID 6153937
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Bleomycin, busulphan, and methotrexate are by far the commonest cytotoxic drugs to cause interstitial pneumonitis. However, many other cytotoxic drugs have been reported to produce similar lung damage. Combined effects of these drugs, and of the drugs with other agents that cause lung damage, such as oxygen and radiation, may result in enhancement of lung damage. Early diagnosis, made possible by awareness of this complication and its correct investigation, may reduce severe morbidity and mortality. In some instances, factors that predispose to lung damage are known, and these have been studied in experimental animals.

Citing Articles

Effects of neoadjuvant chemotherapy on respiratory function in patients with breast cancer.

Ding L, Wang L, Yin J, Fan Z, He Z Chin J Cancer Res. 2020; 32(1):36-42.

PMID: 32194303 PMC: 7072022. DOI: 10.21147/j.issn.1000-9604.2020.01.05.


Mycophenolate Mofetil and Pulmonary Fibrosis After Kidney Transplantation: A Case Report.

Takahashi K, Go P, Stone C, Safwan M, Putchakayala K, Kane W Am J Case Rep. 2017; 18:399-404.

PMID: 28408734 PMC: 5398249. DOI: 10.12659/ajcr.902380.


Interactions Between Inflammatory Bowel Disease Drugs and Chemotherapy.

Leung G, Papademetriou M, Chang S, Arena F, Katz S Curr Treat Options Gastroenterol. 2016; 14(4):507-534.

PMID: 27709332 DOI: 10.1007/s11938-016-0109-8.


Bleomycin-Induced Pulmonary Changes on Restaging Computed Tomography Scans in Two Thirds of Testicular Cancer Patients Show No Correlation With Fibrosis Markers.

den Hollander M, Westerink N, Lubberts S, Bongaerts A, Wolf R, Altena R Oncologist. 2016; 21(8):995-1001.

PMID: 27328932 PMC: 4978551. DOI: 10.1634/theoncologist.2015-0451.


Complications associated with chemotherapy in testicular cancer management.

Fung C, Vaughn D Nat Rev Urol. 2011; 8(4):213-22.

PMID: 21403662 DOI: 10.1038/nrurol.2011.26.


References
1.
Gould V, Miller J . Sclerosing alveolitis induced by cyclophosphamide. Ultrastructural observations on alveolar injury and repair. Am J Pathol. 1975; 81(3):513-30. PMC: 2032338. View

2.
Richter J, Hastedt R, Dalton J, Marshall D, Raymond L . Pulmonary toxicity of bischloronitrosourea: report of a case with transient response to corticosteroid therapy. Cancer. 1979; 43(5):1607-12. DOI: 10.1002/1097-0142(197905)43:5<1607::aid-cncr2820430507>3.0.co;2-0. View

3.
Blum R, Carter S, Agre K . A clinical review of bleomycin--a new antineoplastic agent. Cancer. 1973; 31(4):903-14. DOI: 10.1002/1097-0142(197304)31:4<903::aid-cncr2820310422>3.0.co;2-n. View

4.
Andre R, ROCHANT H, Dreyfus B, Duhamel G, Pechere J . [Diffuse interstitial fibrosis of the lung in Hodgkin's disease treated by high doses of endoxan]. Bull Mem Soc Med Hop Paris. 1967; 118(12):1133-41. View

5.
Mark G, Ragsdale B . Cyclophosphamide pneumonitis. Thorax. 1978; 33(1):89-93. PMC: 470852. DOI: 10.1136/thx.33.1.89. View